Haoxi Health Technology Limited(HAO)Earnings, Financials & Key Ratios
HAO•NASDAQ
$1.10
0.8× P/E·Price updated Jul 6, 2026
SectorCommunication ServicesIndustryAdvertising & MarketingSub-IndustryPerformance and commerce marketing
AboutHaoxi Health Technology Limited, through its subsidiaries, provides online marketing solutions in China. It offers online marketing solutions, including online short video marketing solutions to advertisers through its media partners; and customized marketing solutions by planning, producing, placing, and optimizing online ads to help advertisers acquire, convert, and retain consumers on various online media platforms. The company places its ads through mainstream online short video and social media platforms, such as Toutiao, Douyin, WeChat, and Sina Weibo. It serves advertiser client base primarily in the healthcare industry. The company was founded in 2018 and is based in Beijing, China.Show more
- Revenue$33M-32.4%
- EBITDA-$2M-194.2%
- Net Income$4M+200.1%
- EPS (Diluted)1.32+24.5%
- Gross Margin2.83%-50.1%
- EBITDA Margin-4.96%-239.4%
- Operating Margin-6.1%-272.3%
- Net Margin11.82%+343.9%
- ROE27.06%+34.5%
HAO Price & Volume
Haoxi Health Technology Limited (HAO) stock price & volume — 10-year historical chart
Loading chart...
Structural Revenue Contraction Masks Operational Fragility
Investment Thesis • Updated 2026Q2
VerdictNegative
Growth:Contracting
Profitability:Negative
Financial:Healthy
Cash Flow:Deteriorating
Primary Risk:Regulatory and margin compression
Key Thesis Takeaways
- Haoxi Health Technology faces significant headwinds as its transactional advertising model struggles to maintain growth, evidenced by a recent -32.39% year-over-year revenue decline.
- The company's reliance on non-operating items to mask core losses, combined with razor-thin gross margins of 2.83%, suggests a high sensitivity to regulatory and platform-level fee volatility.
- Investors should remain cautious as the firm's inability to generate consistent free cash flow, which remains negative, threatens the sustainability of its $16.0M equity base.
Verdict Logic
the company's core business model is currently consuming cash with a negative operating margin of -16.8% and a lack of consistent free cash flow generation.
HAO Growth Metrics
Haoxi Health Technology Limited (HAO) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR
Revenue CAGR
10 Years-
5 Years-
3 Years26.63%
TTM53.23%
Profit CAGR
10 Years-
5 Years-
3 Years151.19%
TTM-233.6%
EPS CAGR
10 Years-
5 Years-
3 Years280.3%
TTM-149.39%
Return on Capital
10 Years192.82%
5 Years192.82%
3 Years192.82%
Last Year-13.63%
Peers Comparison
Key metrics vs top competitors for Haoxi Health Technology Limited (HAO)
| Company | Price | Market Cap | P/E Ratio | Rev Growth (1Y) | Net Margin | ROE | Div Yield |
|---|---|---|---|---|---|---|---|
| $1.10 | $4.94M | 0.83 | -32.39% | 11.82% | 27.06% | — | |
| $1.74 | $566.61M | -5.61 | -30.65% | -146.01% | -0.11% | — | |
| $0.89 | $26.37M | -3.41 | 15.17% | -3.05% | -15.02% | — | |
| $2.05 | $1.08M | -0.01 | -82.47% | -140.37% | — | — | |
| $0.42 | $8.42M | -0.61 | -3.73% | -64.25% | -9.15% | — | |
| $1.04 | $3.4M | -1.55 | -70.11% | -33.27% | -28.25% | — |
Compare HAO vs Peers
Haoxi Health Technology Limited (HAO) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
Get notified when HAO posts new earnings or crosses analyst targets
Free. No account needed. Unsubscribe any time.
HAO Frequently Asked Questions
Haoxi Health Technology Limited (HAO) stock FAQ — growth, dividends, profitability & financials explained
Growth & Financials
What is Haoxi Health Technology Limited's revenue?
Haoxi Health Technology Limited (HAO) reported $91.6M in revenue for fiscal year 2025. This represents a 613% increase from $12.8M in 2021.
How fast is Haoxi Health Technology Limited growing?
Haoxi Health Technology Limited (HAO) saw revenue decline by 32.4% over the past year.
Is HAO profitable?
Haoxi Health Technology Limited (HAO) reported a net loss of $2.5M for fiscal year 2025.
Dividend & Returns
What is HAO's return on equity?
Haoxi Health Technology Limited (HAO) has a return on equity (ROE) of 27.1%. This is excellent, indicating efficient use of shareholder capital.
What is Haoxi Health Technology Limited's free cash flow?
Haoxi Health Technology Limited (HAO) had negative free cash flow of $6.7M in fiscal year 2025, likely due to heavy capital investments.